论文部分内容阅读
目的 探讨YL— 1型穿刺针进行清除急性脑出血的临床疗效。方法 采用YL— 1型穿刺针进行清除急性脑出血 3 1例 (治疗组 )与锥颅置硅胶脑式引流管引流术 (对照组A )、内科保守治疗 (对照组B)进行比较。结果 治疗组的血肿平均总清除率达 90 .3 9% ,治疗总有效率达 80 .65 % ;对照组A的血肿平均总清除率达 5 4.66% ,治疗总有效率达 5 3 .13 % ;对照组B的血肿平均吸收率达 2 0 .5 0 % ,治疗总有效率达 2 4.2 4% ;治疗组和对照组A治疗前后、治疗组和对照组A对照组B治疗后的神经功能缺损积分值比较 ,有统计学意义(P <0 .0 1) ;治疗组治疗后的神经功能恢复明显优于对照组A、对照组B。结论 采用YL— 1型穿刺针进行清除急性脑出血 ,血肿清除率高 ,临床疗效好 ,能提高病人生存质量 ,改善病残程度 ,降低致残率及病死率。
Objective To investigate the clinical efficacy of YL-1 type puncture needle in the treatment of acute cerebral hemorrhage. Methods 31 cases of acute cerebral hemorrhage (treatment group) were treated with YL - 1 type puncture needle and brain drainage of cerebral drainage tube (control group A) and conservative treatment of internal medicine (control group B). Results In the treatment group, the average total hematoma clearance rate was 90.39% and the total effective rate was 80.65%. The average total hematoma clearance rate was 4.66% in control group A and the total effective rate was 53.13% ; Control group B hematoma average absorption rate of 20.55%, the total effective rate of 22.44%; treatment group and control group A before and after treatment, the treatment group and control group A control group B after treatment of nerve function The scores of defect integral were statistically significant (P <0.01). The recovery of neurological function of the treatment group was obviously better than that of the control group A and the control group B after treatment. Conclusion YL-1 needle for acute cerebral hemorrhage, high hematoma clearance rate, good clinical efficacy, can improve the quality of life of patients, improve the degree of disability, reduce morbidity and mortality.